Taken together, both AML patients and cell lines which aberrantly express IRX homeobox genes IRX1, IRX3 and IRX5 have been reported, reflecting their contribution to regulatory networks controlling myelopoiesis and driving differentiation arrest (Figure 7). This evidence concerns the gene IRX1 and acute myeloid leukemia.